ADH-1, an N-cadherin antagonist, inhibits N-cadherin mediated cell adhesion.
CAT No: HB00096
CAS No:229971-81-7
Synonyms/Alias:Exherin;229971-81-7;ADH-1;ADH 1;Exherin free base;Cys-his-ala-val-cys;B058ME29VU;NSC-729477;DTXSID4044036;229971-81-7 (free base);L-Cysteinamide, N-acetyl-L-cysteinyl-L-histidyl-l-alanyl-L-valyl-, cyclic (1-5)-disulfide;NSC 729477;(4R,7S,10S,13S,16R)-13-((1H-imidazol-5-yl)methyl)-16-acetamido-7-isopropyl-10-methyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraazacycloheptadecane-4-carboxamide;(4R,7S,10S,13S,16R)-16-acetamido-13-(1H-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide;UNII-B058ME29VU;ADH-1 pepide;CHEMBL3818130;SCHEMBL13857500;DTXCID401012044;EX-A3549;ADH-10001;AKOS030526741;CS-3450;DA-63339;HY-13541;D83667;Q4651113;BRD-K81795818-019-01-4;C518575000;
Exherin, also known as ADH-1 or N-Acylated Hexapeptide, is a synthetic cyclic peptide that functions as a selective antagonist of N-cadherin-mediated cell-cell adhesion. Designed to disrupt specific protein-protein interactions, Exherin has garnered considerable attention in scientific research for its ability to modulate cellular adhesion processes, making it a valuable tool in the study of cell signaling, migration, and tissue remodeling. Its unique structure allows it to bind selectively to N-cadherin, thereby blocking downstream signaling pathways that are critical in various physiological and pathological contexts. Exherin's versatility and targeted mechanism of action provide researchers with a precise approach to dissecting the roles of cadherins in complex biological systems.
Cancer Biology Research: In the field of cancer biology, Exherin is extensively utilized for investigating the mechanisms underlying tumor cell invasion and metastasis. By inhibiting N-cadherin-dependent interactions, researchers are able to study how the disruption of cell-cell adhesion influences epithelial-to-mesenchymal transition (EMT), a pivotal process in cancer progression. This peptide serves as a powerful experimental agent to delineate the molecular events that enable malignant cells to detach from primary tumors and invade surrounding tissues. Its application has advanced the understanding of how targeting adhesion molecules may impact tumor microenvironment dynamics and metastatic potential.
Angiogenesis Studies: The role of Exherin in angiogenesis research is another prominent application. By interfering with N-cadherin interactions between endothelial cells and pericytes, the compound enables detailed analysis of blood vessel formation and stabilization. Scientists use this peptide to dissect the signaling cascades that regulate vascular integrity, permeability, and remodeling. Such studies are instrumental in revealing how cell adhesion influences neovascularization in both physiological and pathological conditions, including tissue repair and abnormal vessel growth.
Cell Migration and Invasion Assays: Exherin is frequently employed in cell migration and invasion assays to elucidate the contribution of N-cadherin to cell motility. By blocking specific adhesion pathways, the compound allows for the assessment of how cells navigate through extracellular matrices, which is essential for understanding processes such as wound healing, tissue regeneration, and metastatic dissemination. The peptide's ability to selectively disrupt N-cadherin function provides a refined experimental approach to studying cell movement in various model systems.
Neuroscience Research: Within neuroscience, Exherin is applied to explore the role of cadherin-mediated adhesion in neural development and synaptic plasticity. Its selective inhibition of N-cadherin provides insights into how cell adhesion molecules contribute to axon guidance, synapse formation, and neural network remodeling. By employing this peptide, researchers can dissect the complex interplay between structural connectivity and functional plasticity in the nervous system, shedding light on fundamental mechanisms of brain development and adaptation.
Tissue Engineering and Regenerative Medicine: The application of ADH-1 extends to the fields of tissue engineering and regenerative medicine, where modulation of cell adhesion is critical for tissue formation and integration. Researchers utilize this compound to control cell-cell interactions in engineered tissues, facilitating studies on scaffold design, cellular organization, and tissue maturation. By regulating N-cadherin activity, Exherin aids in optimizing conditions for the development of functional tissue constructs and enhancing the integration of transplanted cells with host tissues.
In summary, the diverse applications of Exherin encompass cancer biology research, angiogenesis studies, cell migration and invasion assays, neuroscience research, and advancements in tissue engineering. Its targeted mechanism of action and specificity for N-cadherin make it an indispensable tool for scientists aiming to unravel the complexities of cell adhesion and signaling in health and disease. Through its use, researchers are able to gain deeper insights into fundamental biological processes and develop innovative strategies for addressing challenges across multiple domains of biomedical science.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.